Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)

NCT06122285 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis D

Interventions

DRUG: Bulevirtide

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico